YSEI SHH-HWD-2 Series Drug Stability Testing Chamber

Overview

The YSEI SHH-HWD-2 Series Drug Stability Testing Chamber is an engineered environmental simulation system designed specifically for accelerated stability studies in compliance with international pharmaceutical regulatory frameworks. It operates on a forced-air convection principle with dual-wall insulated construction, precision-controlled heating elements, and a high-efficiency refrigeration circuit—enabling stable, uniform, and reproducible thermal conditions across the entire working volume. This chamber meets the core requirements of ICH Q1A(R2) for long-term, intermediate, and accelerated testing conditions—including the 40°C ±2°C / 75% RH ±5% RH and 60°C ±2°C dry heat protocols. Its architecture supports Good Manufacturing Practice (GMP)-aligned workflows, with traceable temperature control, audit-ready data capture, and built-in redundancy for critical safety functions.

Key Features

• PID-driven dual-sensor temperature control system with mechanical overtemperature cut-off independent of main controller—ensuring fail-safe operation during extended unattended runs.
• Modular RS-485 communication interface compliant with Modbus RTU protocol, enabling seamless integration into centralized laboratory monitoring systems (LMS) or SCADA platforms.
• Dual-channel data recording: real-time digital logging to external PC (with timestamped CSV export) plus optional thermal printer output (configurable print intervals from 1 to 60 minutes).
• Remote web-based supervision via embedded HTTP server—supports secure authentication, live parameter viewing, event log download, and remote firmware update verification (no physical access required).
• Energy-optimized thermal design: low-power heating elements combined with variable-speed condenser fan and high-density polyurethane insulation (≥80 mm thickness) reduce operational energy consumption by ≥25% versus legacy chambers.
• Acoustically damped enclosure and vibration-isolated compressor mount achieve ≤52 dB(A) noise emission—suitable for shared lab environments without dedicated mechanical rooms.

Sample Compatibility & Compliance

The SHH-HWD-2 series accommodates standard pharmaceutical packaging formats including blister cards, HDPE bottles, glass vials (up to 100 mL), and aluminum-laminated pouches. Chamber interior is constructed from electropolished stainless steel (AISI 304), resistant to corrosion from residual solvents or humidity-induced condensate. All operational parameters and validation documentation align with FDA 21 CFR Part 11 requirements for electronic records and signatures. IQ/OQ documentation packages—including installation checklists, sensor calibration certificates (NIST-traceable), mapping reports (per ISO 16770:2021), and protocol execution records—are provided as part of standard delivery. The system supports full GxP audit readiness with configurable user access levels, electronic signature enforcement, and immutable audit trails for all configuration changes.

Software & Data Management

Data acquisition is handled through native Windows-compatible software (YSEI StabilityLink™ v3.2), supporting automated generation of ICH-aligned stability reports (including trend analysis, shelf-life estimation per Arrhenius modeling, and failure mode annotation). Raw temperature/humidity logs are stored in encrypted SQLite databases with SHA-256 hash integrity verification. Export options include PDF (with digital signature), CSV (for statistical analysis in JMP or Minitab), and XML (for LIMS ingestion). All data files contain embedded metadata: instrument ID, operator login, environmental context tags (e.g., “Accelerated_60C_Dry”), and hardware revision fingerprints—ensuring full ALCOA+ compliance (Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring, Available).

Applications

• ICH Q1A(R2) accelerated stability testing under dry heat (60°C ±2°C) and high-temperature (40°C ±2°C) conditions.
• Forced degradation studies evaluating thermal oxidative pathways in APIs and finished dosage forms.
• Package integrity assessment under elevated temperature stress (e.g., seal strength loss, moisture barrier performance).
• Supporting regulatory submissions to FDA, EMA, PMDA, and NMPA with fully documented chamber qualification and ongoing performance verification.
• Long-term stability monitoring at intermediate conditions (30°C ±2°C / 65% RH ±5% RH) when paired with optional humidity module (SHH-HWD-2H variant).

FAQ

Does the SHH-HWD-2 series support 21 CFR Part 11-compliant electronic signatures and audit trails?
Yes. The StabilityLink™ software enforces role-based access control, requires dual-user electronic signatures for critical actions (e.g., test initiation, parameter modification), and maintains immutable, time-stamped audit logs of all system events.
Can temperature mapping be performed in-house using the supplied validation toolkit?
Yes. The IQ/OQ package includes pre-validated mapping procedures, calibrated thermocouple kits (±0.1°C accuracy), and reporting templates aligned with ISO 16770:2021 Annex C.
What is the maximum number of units controllable from a single workstation?
Up to 30 SHH-HWD-2 units can be monitored and managed concurrently via one IP subnet using the centralized dashboard; each unit retains independent setpoint control and alarm logic.
Is humidity control included in the base model?
No. The SHH-HWD-2 is a dry-heat optimized chamber. Humidity capability (30–80% RH) is available in the SHH-HWD-2H variant, which integrates a steam generator and desiccant-based dehumidification system.
How is calibration traceability maintained across the instrument lifecycle?
All factory-installed sensors are calibrated against NIST-traceable references prior to shipment. Calibration certificates—including uncertainty budgets and as-found/as-left data—are included. Field recalibration services are available with certified technician dispatch and post-calibration verification reports.